🇺🇸 FDA
Patent

US 11364211

Methods for selecting phosphatase selective and non-selective phosphatase inhibitors

granted A61KA61K31/155A61P

Quick answer

US patent 11364211 (Methods for selecting phosphatase selective and non-selective phosphatase inhibitors) held by United Kingdom Research and Innovation expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United Kingdom Research and Innovation
Grant date
Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/155, A61P, A61P21/00, A61P25/14